FDA recall D-0550-2023
Northwind Pharmaceuticals LLC · Class II · drug
Product
Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-109-52
Reason for recall
CGMP Deviations
Distribution
Nationwide with the United States
Key facts
- Status
- Ongoing
- Initiation date
- 2023-03-16
- Report date
- 2023-05-03
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Indianapolis, IN, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0550-2023